Document is current
Any future updates will be listed below
-
Authors
Talarico, M.
Barbato, S.
Maisnar, V.
Delimpasi, S.
Puppi, M.
Rizzello, I.
Pantani, L.
Tacchetti, P.
Martello, M.
Vigliotta, I.
Terragna, C.
Cavo, M.
Zamagni, Elena
Mancuso, K.
-
Funding
Funding for this research was provided by:
Alma Mater Studiorum - Università di Bologna
- License Information
-
More Information
Article History
Received: 14 May 2025
Accepted: 11 September 2025
First Online: 9 October 2025
Declarations
:
: IR has received honoraria from Amgen, GlaxoSmithKline and Sanofi and advisory role for GlaxoSmithKline; LP has received honoraria from GlaxoSmithKline, Pfizer and Sanofi; PT has received honoraria from Amgen, Bristol-Myers Squibb/Celgene, Janssen, Takeda, AbbVie, Sanofi, GlaxoSmithKline and Pfizer; MC has served in a consulting/advisory role for and has received honoraria from Amgen, AbbVie, Bristol-Myers Squibb, Celgene, GlaxoSmithKline, Janssen, Menarini-Stemline, Sanofi, and Karyopharm Therapeutics; EZ has received honoraria and has served in advisory role for Janssen, Bristol-Myers Squibb, Sanofi, Amgen, GlaxoSmithKline, Pfizer, Oncopeptides, Menarini-Stemline; KM honoraria from Celgene, Takeda, Amgen, Sanofi and Janssen. SB, VM, SD, MP, MM, IV, CT declare no potential conflicts of interest.
: This retrospective review of patient data did not require ethical approval in accordance with local/national guidelines. Written informed consent was obtained from the patient for publication of the details of their medical case and any accompanying images.
